Rachel Musomba, Barbara Castelnuovo, Claire V. Murphy, C Komujuni, Patience Nyakato, Ponsiano Ocama, Mohammed Lamorde, Philippa Easterbrook, Rosalind Parkes-Ratanshi
Joan Nankya-Mutyoba, Jim Aizire, Fredrick Makumbi, Lynn Atuyambe, Ponsiano Ocama, Gregory D. Kirk
Countries in sub-Saharan Africa with a high hepatitis B burden also have limited resources to identify underlying drivers of disease among key at-risk populations. To improve prioritization and strengthen prevention of mother to child transmission of HBV, it is imperative to understand disease awareness, knowledge and related factors among pregnant women. This study assessed HBV disease awareness,...... hiện toàn bộ
Jeffrey V. Lazarus, Antons Mozalevskis, Kelly Safreed-Harmon, Irina Eramova
Hepatitis B and C are major public health threats in the World Health Organization (WHO) European Region. Viral hepatitis surveillance shortcomings have resulted in many WHO Member States having insufficient data available to guide decision-making. This study describes surveillance in the region based on a quantitative sub-analysis of findings from the 2013 WHO viral hepatitis policy report and a ...... hiện toàn bộ
After introduction of new direct acting antivirals (DAAs) against hepatitis C, the cure rate has increased substantially especially in patients with liver cirrhosis. Decreased but remaining risk for hepatocellular carcinoma (HCC) has been shown in patients with liver cirrhosis after cure, in previous studies with interferon (IFN)-based treatments. This risk for HCCs is expected to become the next ...... hiện toàn bộ
Debra A. O’Leary, Eleanor Cropp, David Isaac, Paul V. Desmond, Sally Bell, Tin Nguyen, Darren Wong, Jessica Howell, Jacqui Richmond, Jenny O’Neill, Alexander J. Thompson
The current model of care for the treatment of chronic hepatitis B (CHB) in Australia is through specialist Hepatology or Infectious Diseases clinics, and limited accredited primary care practices. Capacity is limited, and less than 5% of Australians living with CHB currently access therapy. Increasing treatment uptake is an urgent area of clinical need. Nucleos(t)ide analogue therapy is safe and ...... hiện toàn bộ